Уважаемые коллеги, пожалуйста помогите со следующими публикациями.
Заранее благодарю всех откликнувшихся
1.Stowe, G. N., P. Silhar, et al. (2010). "Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease." Org Lett 12(4): 756-759.
- DOI:
http://dx.doi.org/10.1021/ol902820z
2.Kukreja, R. V., S. K. Sharma, et al. (2010). "Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E." Biochemistry 49(11): 2510-2519.
- DOI:
http://dx.doi.org/10.1021/bi902096r
3.Shi, X., J. E. Curran, et al. (2009). "The biological activity of ubiquitinated BoNT/B light chain in vitro and in human SHSY-5Y neuronal cells." J Cell Biochem 108(3): 660-667
- DOI:
http://dx.doi.org/10.1002/jcb.22300
4. Pickett, A. (2010). "Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects." BioDrugs 24(3): 173-182.
- DOI:
http://dx.doi.org/10.2165/11534510-000000000-00000
5.Montal, M. (2010). "Botulinum Neurotoxin: A Marvel of Protein Design." Annu Rev Biochem 79(1):591-617
- DOI:
http://dx.doi.org/10.1146/annurev.biochem.051908.125345
